Cirdan is delighted to announce that it has signed an exclusive agreement with global healthcare firm, Beckton, Dickinson and Company (BD) to distribute its CoreLite™ specimen radiography system in the United States and Canada.

CoreLite™, an innovative x-ray system that helps to speed up breast cancer diagnosis, is currently being distributed by BD throughout Europe.

Cirdan produces a suite of informatics and imaging solutions alongside CoreLite™ from its Lisburn headquarters, including the world-class ‘ULTRA’ Laboratory Information System (LIS) which is designed to support clinical laboratory operations.

The new deal will see BD’s sales team promote CoreLite™ across the US and Canada, further strengthening the existing relationship between the two companies.

Speaking about the new partnership, Stephen Dunniece, Cirdan CTO commented:

“We are delighted to partner with BD and to expand our imaging operations to the USA and Canada. We have an existing presence in North America with our LIS business, but this is an exciting new development for our imaging division.”

He added: “As a team we are extremely proud of creating a product like CoreLite™, which offers benefits like improved patient experience and reduced clinical procedure time. We’re excited that with the help of BD we will be able to expand the reach of this product and undoubtedly make a positive impact on people’s lives.”

Jennifer Lutjen, Director of Global Marketing at BD said:

“We were looking for a product that would complement our market leading breast biopsy systems and enhance our offering to our customers. CoreLite™ was the perfect fit for us!  We have enjoyed a successful partnership with Cirdan in Europe, and we are looking forward to building on this here in the US.”